These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36948667)

  • 1. Diseases of Hereditary Renal Cell Cancers.
    Iliopoulos O
    Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
    Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
    Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary Renal Cancer Syndromes.
    Yanus GA; Kuligina ES; Imyanitov EN
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Strategies for Hereditary Kidney Cancer: Current Recommendations and Updates.
    Singh S; Chaurasia A; Gopal N; Malayeri A; Ball MW
    Discov Med; 2022; 34(173):205-220. PubMed ID: 36602871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary kidney cancer: unique opportunity for disease-based therapy.
    Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
    Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Renal Cell Carcinoma Syndromes.
    Carlo MI
    Hematol Oncol Clin North Am; 2023 Oct; 37(5):841-848. PubMed ID: 37258351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.
    Kallinikas G; Habib H; Tsimiliotis D; Koutsokostas E; Bokor B
    Int Urol Nephrol; 2017 Sep; 49(9):1507-1512. PubMed ID: 28567709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of hereditary renal cancer syndromes: a pending issue for oncologists.
    García-Donas J; Hernando S; Romero N; Jara C
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S15-20. PubMed ID: 21173603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
    Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
    Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumarate hydratase as a therapeutic target in renal cancer.
    Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G
    Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited renal carcinomas.
    Kawashima A; Young SW; Takahashi N; King BF; Atwell TD
    Abdom Radiol (NY); 2016 Jun; 41(6):1066-78. PubMed ID: 27108134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary kidney cancer syndromes.
    Haas NB; Nathanson KL
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):81-90. PubMed ID: 24359990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic kidney cancer syndromes.
    Ho TH; Jonasch E
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
    Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ
    Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
    Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
    Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
    Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary renal tumor syndromes.].
    Sánta F; Semjén D; Kuthi L
    Orv Hetil; 2023 Mar; 164(10):363-375. PubMed ID: 36906860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Case of Synchronous Fumarate Hydratase-Deficient Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma With Fumarate Hydratase and von Hippel-Lindau Gene Mutations: A Clinicopathologic and Molecular Study.
    Wen H; Zheng L; Zhang M; Pan X; Wang D; Qian J; Zhang X; Zhou Q; Chen N
    Int J Surg Pathol; 2024 Jun; 32(4):810-816. PubMed ID: 37715637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis.
    Alchoueiry M; Cornejo K; Henske EP
    Semin Diagn Pathol; 2024 Jan; 41(1):1-7. PubMed ID: 38008653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.